Radiologic complete response (rCR) in contrast-enhanced magnetic resonance imaging (CE-MRI) after neoadjuvant chemotherapy for early breast cancer predicts recurrence-free survival but not pathologic complete response (pCR)

BACKGROUND: Patients with early breast cancer (EBC) achieving pathologic complete response (pCR) after neoadjuvant chemotherapy (NACT) have a favorable prognosis. Breast surgery might be avoided in patients in whom the presence of residual tumor can be ruled out with high confidence. Here, we invest...

Descripción completa

Detalles Bibliográficos
Autores principales: Gampenrieder, Simon Peter, Peer, Andreas, Weismann, Christian, Meissnitzer, Matthias, Rinnerthaler, Gabriel, Webhofer, Johanna, Westphal, Theresa, Riedmann, Marina, Meissnitzer, Thomas, Egger, Heike, Klaassen Federspiel, Frederike, Reitsamer, Roland, Hauser-Kronberger, Cornelia, Stering, Katharina, Hergan, Klaus, Mlineritsch, Brigitte, Greil, Richard
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6357474/
https://www.ncbi.nlm.nih.gov/pubmed/30704493
http://dx.doi.org/10.1186/s13058-018-1091-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6357474/
https://www.ncbi.nlm.nih.gov/pubmed/30704493
http://dx.doi.org/10.1186/s13058-018-1091-y

Ejemplares similares